$Atopic-eczema-associated fracture risk and oral corticosteroids: a population-based cohort study$

Atopic-eczema-associated fracture risk and oral corticosteroids: a population-based cohort study

<p><strong>Background:</strong> Evidence suggests adults with atopic eczema have increased fracture risk. However, it is unclear whether oral corticosteroids explain the association.</p> <p><strong>Objective:</strong> To assess to what extent oral corticost...

Full description

Bibliographic Details
Main Authors:	Matthewman, J, Mansfield, KE, Prieto-Alhambra, D, Mulick, AR, Smeeth, L, Lowe, KE, Silverwood, RJ, Langan, SM
Format:	Journal article
Language:	English
Published:	Elsevier 2021

Similar Items

Atopic eczema and fracture risk in adults: a population-based cohort study
by: Lowe, K, et al.
Published: (2019)

Cost evaluation in atopic eczema
by: Gieler, U, et al.
Published: (1999)

Use of oral corticosteroids and risk of fractures.
by: Van Staa, T, et al.
Published: (2000)

Childhood atopic eczema: children’s Quality of life and family impact
by: Ghani, Ahmad Abir Ab
Published: (2012)

The role of Der p 1 specific T cells in atopic eczema
by: Chan, H, et al.
Published: (2013)

Validation of the recap of atopic eczema (RECAP) measurement instrument for eczema control in adult patients in an Asian clinical setting
by: Yew, Yik Weng, et al.
Published: (2024)

Children and the risk of fractures caused by oral corticosteroids.
by: van Staa, T, et al.
Published: (2003)

Use of oral corticosteroids and risk of fractures. June, 2000.
by: Van Staa, T, et al.
Published: (2005)

Antioxidant profiles of a prepared extract of Chinese herbs for the treatment of atopic eczema
by: Chung, L.Y.
Published: (2008)

Antigen dose and keratinocyte antigen presentation are specific determinants of T cell function in atopic eczema
by: Chan, H, et al.
Published: (2011)

Oral corticosteroids and fracture risk: relationship to daily and cumulative doses.
by: van Staa, T, et al.
Published: (2000)

Molluscum contagiosum and associations with atopic eczema in children: a retrospective longitudinal study in primary care
by: Olsen, JR, et al.
Published: (2015)

IL-17A and IL-22 cause down-regulation of filaggrin - implications for the pathogenesis of atopic eczema
by: Gutowska-Owsiak, D, et al.
Published: (2010)

Inhaled corticosteroids and hip fracture: Disease or drugs? [2] (multiple letters)
by: Van Staa, T, et al.
Published: (2003)

COPD: an inhaled corticosteroid-resistant, oral corticosteroid-responsive condition.
by: Saha, S, et al.
Published: (2006)

A machine-learning exploration of the exposome from preconception in early childhood atopic eczema, rhinitis and wheeze development
by: Dong, Yizhi, et al.
Published: (2024)

Interleukin-17 and interleukin-22 contribute to alterations in epidermal function via multiple pathways - role in atopic eczema
by: Gutowska-Owsiak, D, et al.
Published: (2011)

Inhaled corticosteroids and risk of fractures
by: Van Staa, T, et al.
Published: (2000)

Oral and topical corticosteroids in bullous pemphigoid.
by: Ardern-Jones, MR, et al.
Published: (2002)

Oral and topical corticosteroids in bullous pemphigoid
by: Ardern-Jones, MR, et al.
Published: (2002)

How to use the harmonising outcome measures for eczema core outcome set for atopic dermatitis trials: a users' guide
by: Thomas, Kim S., et al.
Published: (2024)

Predictors of fracture while on treatment with oral bisphosphonates: a population-based cohort study.
by: Prieto-Alhambra, D, et al.
Published: (2014)

Use of inhaled corticosteroids and risk of fractures.
by: van Staa, T, et al.
Published: (2001)

Filaggrin null mutations associate with increased frequencies of allergen-specific CD4+ T-helper 2 cells in patients with atopic eczema.
by: Mcpherson, T, et al.
Published: (2010)

Predictors of second fracture while on treatment with oral bisphosphonates: a multinational cohort study
by: Hawley, S, et al.
Published: (2014)

Formulation for the treatment of eczema
by: Neo, Rui Qi
Published: (2017)

Knowledge, attitude and practices of South African healthcare professionals towards complementary and alternative medicine use for atopic eczema – a descriptive survey
by: Thandar, Y, et al.
Published: (2016)

Inhaled corticosteroids and hip fracture: disease or drugs?
by: van Staa, T, et al.
Published: (2003)

Effect of intra-articular corticosteroid injections for osteoarthritis on the subsequent use of pain medications: a UK CPRD cohort study
by: Hawley, S, et al.
Published: (2025)

The association between calcium ± vitamin D supplementation and fracture risk among incident users of oral bisphosphonates: a population-based cohort study
by: Reyes, C, et al.
Published: (2015)

Are inhaled corticosteroids associated with an increased risk of fracture in children?
by: van Staa, T, et al.
Published: (2004)

Higher maternal serum concentrations of nicotinamide and related metabolites in late pregnancy are associated with a lower risk of offspring atopic eczema at age 12 months.
by: El-Heis, S, et al.
Published: (2016)

The use of a large pharmacoepidemiological database to study exposure to oral corticosteroids and risk of fractures: validation of study population and results.
by: Van Staa, T, et al.
Published: (2000)

Use of oral corticosteroids and risk of fractures (reprinted from JBMR, vol. 15, pg. 993-1000, yr. 2000)
by: Van Staa, T, et al.
Published: (2005)

Association between prenatal depressive symptoms and eczema in infants: The Born in Guangzhou Cohort Study
by: Wei, D, et al.
Published: (2020)

Oral corticosteroid-dependent asthma: current knowledge and future needs
by: Pavord, I
Published: (2019)

Public health impact of adverse bone effects of oral corticosteroids.
by: van Staa, T, et al.
Published: (2001)

Managing Staphylococcus aureus in eczema - Introduction
by: Hobbs, R
Published: (1999)

A meta-analysis of prior corticosteroid use and fracture risk.
by: Kanis, J, et al.
Published: (2004)

The use of inhaled corticosteroids is not associated with an increased risk of fracture in children.
by: van Staa, T, et al.
Published: (2001)